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Abstract: Although stress is an adaptive physiological response to deal with adverse 
conditions, its occurrence during early stages of life such as infancy or adolescence can induce 
adaptations in multiple physiological systems, including the reproductive axis (HPG), the 
hypothalamic-pituitary-adrenal (HPA) axis, the limbic cortex and the immune system. These early 
changes have consequences in adult life, as seen in the physiological and behavioral responses to 
stress. This review highlights the impact of several stress challenges incurred at various stages of 
development (peri-natal, juvenile, adolescent periods) and how developmental timing of early life 
stress confers unique physiological adaptations that may persist across the lifespan. In doing so, we 
will emphasize how intrinsic sex differences in the stress response might contribute to sex-specific 
vulnerabilities, the molecular processes underlying stress in the adult, and potential therapeutic 
interventions to mitigate the effects of early stage stress, including the novel molecular mechanism 
of SUMOylation as a possible key target of HPA regulation during early life stress. 
 
Introduction  
Although originally cast in relation to gestational effects, the concept of developmental 
vulnerability to early life insults and its relationship to subsequent health-related outcomes is well-
established in the Developmental Origins of Health and Disease hypothesis [1], which states that 
stress during development increases the risk of diseases in adult life. A rich literature has therefore 
examined the influence of threats imposed during the prenatal, early postnatal and childhood 
periods on subsequent health outcomes in adulthood [2]. The past decade, however, has witnessed 
increasing recognition that developmental vulnerability to such threats extends into adolescence in 
humans, with many of these developmental vulnerabilities being aptly modeled in pre-clinical model 
organisms [3]. Considering that early stages of development are periods of profound neural and 
behavioral change, during which developing organisms transition to adult-like functioning [4], it is 
crucial for ongoing studies to examine developmental vulnerabilities in these periods. 
Importantly, early stages of development often include exposure to major life stressors, 
acute infection, and the initiation of alcohol consumption. Although most studies tend to segregate 
these seemingly independent challenges, stress, alcohol and infection share a wide range of 
immediate, over-lapping physiological consequences. For instance, stress, alcohol and infection all 
produce robust activation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to increased 
circulating corticosteroids (corticosterone in rat and mouse; cortisol in humans) and subsequent 
activation of glucocorticosteroid receptors (GR), (e.g., [5]). Furthermore, all 3 challenges significantly 
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like behavioral responses as a consequence [6]. Finally, and perhaps most importantly, exposure to 
stress, alcohol or infection during early development has been shown to produce alterations in HPA 
axis activation and cytokine reactivity that persist into adulthood [7], and perhaps across the 
lifespan. Thus, examination of common physiological outcomes and mechanisms between early life 
stress, alcohol exposure and immune challenge has the potential to rapidly advance our 
understanding of developmentally-entrained alterations in multiple health and disease-related 
outcomes.  
 
Early life consequences of alcohol, infection and stress: a common role for inflammation?  
i. Alcohol consumption:  
Alcohol consumption during pregnancy and developmental disorders with consequences in 
adult life have been linked during the last few decades, however, studies are increasingly being 
focused on adolescence, which is a critical cognitive and neuroimmune developmental period and 
one where alcohol intake usually begins in humans. A recent study in rats demonstrated that 
adolescent males at postnatal day (PND) 28-32 displayed severely blunted cytokine changes across 
the central nervous system (CNS) when challenged with alcohol or lipopolysaccharide (LPS) relative 
to young adults (PND 70-74) [8]. These findings are consistent with other studies suggesting 
functional immaturity of microglia in adolescence [9], and could suggest that the lack of a mature, 
functional neuroimmune response in adolescence may be critical to certain adolescent 
vulnerabilities. Several studies have demonstrated that alcohol consumption during adolescence 
leads to adult phenotypes in adulthood, including the further responses to an immunological 
challenge [3]. For instance, adult male rats with a history of adolescent binge-like alcohol exposure 
[10] showed suppressed expression of pro-inflammatory cytokines by circulating immune cells in 
response to an immunological stressor such as LPS, with no changes in plasma corticosterone (CORT) 
whatsoever [7]. On the contrary, adult female rats exposed to alcohol during adolescence did not 
show the pro-inflammatory cytokine suppression in response to LPS, but rather displayed a 
sensitized CORT response. Importantly, these patterns of immunosuppression in males were 
observed when rats with a history of intermittent alcohol exposure were challenged as adults with 
restraint or LPS (but not with adult alcohol challenge), suggesting long-term functional changes in 
immune reactivity as a result of adolescent alcohol exposure. Thus, adolescent alcohol exposure led 
to profound, sex-specific outcomes indicating that the systems influenced by adolescent alcohol 
were completely different for males and females [7], a scenario which should be taken into account 
in future studies dealing with the effects of adolescent alcohol exposure. 
 
ii. LPS challenge  
It has been demonstrated that an immune challenge during early stages of life induces 
reprogramming events at the CNS level which manifest into adulthood [11]. Cytokine expression 
during early life stages has been associated with further development of neuropsychiatric disorders 
in adulthood. Neonatal LPS administration has been demonstrated to increase hypothalamic, 
hippocampal and prefrontal cortex (PFC) levels of interleukin (IL)-4 and decrease IL-6 levels in both 
adolescence and adulthood of males and females, and these changes may induce behavioural 
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challenge during neonatal periods can modify further responses to different types of stress. For 
example, neonatal treatment with LPS enhanced hippocampal IL-1β induced by restraint stress in 
adulthood in both male and female rats, and also tumor necrosis factor-α (TNFα) levels in males 
[13]. On the other hand, LPS-challenge in neonatal male rats subsequently treated with the same 
dose of the endotoxin during adulthood showed no changes in plasma TNFα and IL-1β compared to 
adult saline-treated rats, but showed reduced LPS fever response [14]. However, neonatal immune 
challenge enhanced the effect of adult LPS exposure on the expression of the hypothalamic 
cytokines IL-1β and TNFα in male rats, and these effects were associated with body weight 
regulation systems [15]. Focusing on the sex specific effects of an early immune challenge on the 
CNS, it has been shown that typical colonization by microglia occurs much earlier in males than 
females in regions including the hippocampus and neocortex [16]. The morphology of microglia can 
change during development, since adult microglia are known to possess a small cell body with thin 
and long processes, but during injury can be activated, changing their morphology to an amoeboid 
and round shape. Males exhibit a greater number of amoeboid microglia during early development 
(PND 0-4). This early amoeboid shape in males could indicate that these microglia are 
hypersensitive, thereby making them more reactive to stressors during the juvenile period of 
development. Interestingly, female microglia display a more amoeboid phenotype in adolescence, 
when males no longer display this distinct morphology. These sex specific differences in microglial 
colonization and activation state could indicate that males are preferentially susceptible to long-
lasting effects of early-life immune challenge compared to females [9].  
Considering the inflammatory pattern observed in CNS induced by an early immune 
challenge and its influence on further development of neuropsychiatric disorders, it is worthwhile 
highlighting the role of the endocannabinoid system, since it has been demonstrated that the 
expression of the cannabinoid CB2 receptor is enhanced in CNS during inflammatory conditions [17]. 
Particularly, neonatal cortical microglial cells exposed to LPS showed increased levels of pro-
inflammatory cytokines, but cannabinoid administration prevented this effect [18]. Also, an in vivo 
experiment of neonatal LPS exposure in male rats indicated decreased cannabinoid CB1 receptor 
binding in adulthood in the CNS [19], suggesting a potentially important role for the 
endocannabinoid system in linking immune challenge in early life stages with neuropsychiatric 
disorders during adulthood. 
iii. Maternal separation  
Maternal separation (MS) in rats is used as a model of postnatal stress that induces adult 
neurodevelopmental changes. MS entails separation of pups from their mother for 3-4 hrs per day 
during the first 2-3 weeks of life, which disrupts the mother-infant relationship via disorganized 
maternal behavior [20], [21], and imposes direct infant stress when the pups are isolated during the 
separation [22]. In contrast to the consequences of stress exposure in adulthood, developmental 
exposure to stress can affect the trajectory of actively maturing systems that may manifest in 
atypical function after a seeming latent period [23]. For example, it has been suggested that MS 
induces long-lasting alterations in the developing immune system [24], [25], though the mechanistic 
underpinnings of these effects is still not well understood. MS exposure produces changes in 
baseline circulating levels of cytokines that are first apparent in early adolescence - two weeks after 
the stress paradigm was terminated [26]. These findings indicate that adolescence is a critical period 
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Animal models have shown various immunological responses to MS, often with sex-specific 
effects. Particularly, it has been demonstrated that although MS induced no changes associated to 
age or sex in plasma levels of the pro-inflammatory cytokine IL-1β or the modulatory cytokine IL-4, 
males previously exposed to MS for 4 hrs/day from PND 2-20 displayed a transient drop in the 
modulatory cytokine IL-10 in early adolescence (PND 35) [26]. This decrease in IL-10 occurred at an 
age that correlated with the initiation of puberty [26], [27] and with a concurrent decrease in 
circulating testosterone levels, compared to control males [28]. Interestingly, the effects of MS on IL-
10 levels in male rats during puberty may be under testosterone influence, since this hormone 
induces IL-10 expression in male T-cells [28] during puberty [26], [29], [30]. Taken together, early life 
experiences may affect immune signalling in male adolescents indirectly via differential 
development of the HPG axis, as further described below. 
The immune adaptive responses are in part driven by T-helper cells, and since they have 
different types of responses, they are classified into different cellular subtypes. TH1 cytokine 
responses are associated with intracellular responses, whereas TH2 cytokine responses are linked 
with extracellular responses and self-cell tolerance. The importance of IL-10 in the regulation of the 
immune system has been demonstrated since it can modulate both TH1 and TH2 responses in 
different scenarios [31], [32]. Thus, the consequences of MS on circulating IL-10 in males should be 
interpreted in the context of its potential influence on associated immune signals [33]. IL-10 is an 
essential component of the immune regulatory response needed to inhibit pro-inflammatory 
cytokine synthesis, decrease reactive oxygen species, and suppress cytotoxic T-cell responses [33]. 
Therefore, decreases in IL-10 that were observed in adolescent males following MS may exacerbate 
pro-inflammatory signaling mechanisms, with neuro-behavioral consequences. Finally, it should be 
noted that the endocannabinoid system is another potential target for inflammatory deregulation 
induced by MS, since the inhibition of endocannabinoid inactivation was shown to prevent increased 
CORT levels and astrocyte number in the hippocampus - which is associated with oxidative stress 
processes, induced by MS [34]. Further studies are needed to fully understand the potential benefits 
of endocannabinoid modulation in the context of these detrimental processes in early life stages. 
Overall, it is becoming clear that immune activity during critical developmental periods is an 
important mechanism to consider as underpinning long-term effects of early life stress. 
 
iv. Cytokine production: common features 
Taken together, reports indicate that early-life insults evoke further changes in the adult 
immune system. Particularly, one of the most interesting links between early insults and adult 
cognitive disorders are cytokines, since their imbalance is associated with depression and 
schizophrenia. Studies indicate that MS evokes changes in IL-10, IL-6, and TNFα [24], [25], [35], 
ethanol exposure during adolescence alters IL-1β, IL-6 and TNFα [8], and neonatal LPS affects IL-1β, 
IL-4, IL-6, and TNFα in the CNS [12], [15], and all these cytokines have been related to further adult 
cognitive disorders. IL-1β is a pro-inflammatory cytokine with detrimental effects on cognitive 
dysfunction [36]. Its negative effects are known to synergize with other cytokines such as TNFα and 
IL-6, to induce neuron damage [37], and its detrimental effects are also associated with an increase 
craving for alcohol [38]. IL-6 is a modulatory cytokine induced by IL-1 β and TNFα, and its increase 
during early stages of development is associated with autism, and its decrease with higher 
aggression and emotionality [39], [40]. IL-4 is also a modulatory cytokine able to downregulate IL-1 β 
and TNFα production [41], but also with a pro-inflammatory potential [42], and its deregulation is 
associated with autism disorders [12], [43]. Finally, and as explained previously, IL-10 is also a 
modulatory cytokine regulating the immune response, and its deregulation correlated with cognitive 
dysfunction [26]. Table 1 summarizes the principal responses of each cytokine during adulthood, 
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Interactions with neuroendocrine systems: the HPA and HPG axes  
i. HPA  
a. Physiological and developmental outcomes 
The HPA axis is formed by several populations of hormone-secreting cells. One of these 
populations is composed by hypothalamic neurons located in the paraventricular nucleus, which 
secrete corticotropin releasing hormone (CRH) to the adenohypophysis, where another population 
of cells - corticotrophs - are located. Corticotrophs can respond to the hypothalamic neuropeptide 
by releasing adrenocorticotropic hormone (ACTH), which is the stimulus for the third population of 
the axis, the endocrine cells in the zona fasciculata of the adrenal cortex. Adrenal cortical cells 
respond to ACTH by synthetizing glucocorticoid hormones which are released into the circulation, 
and among other effects they can inhibit the release of CRH and ACTH, by a direct feedback 
inhibition. As previously mentioned, stress, alcohol and infection are known to activate the HPA axis, 
increasing circulating CORT and subsequently activating GR (eg., [5]). Notably, adolescent alcohol 
exposure differently affects further responses to stress in adulthood depending on the sex of the 
animals, since male alcohol exposure during adolescence (PND 30-32) evoked no changes in adult 
CORT responses to stress, whereas females displayed an enhanced CORT response [7]. It can be 
noted, however, that adolescent intermittent ethanol has previously been shown to have little effect 
on the normal progression of puberty, suggesting that the effects observed here may be 
independent of pubertal hormones [44]. Sexually dimorphic CORT responses were also found in 
adult rats exposed to an adolescent single session of inescapable footshock (~2 hr of intermittent 
stress), where a robust and time-dependent expression of pro-inflammatory cytokines in the CNS 
was found (e.g., [45]) after footshock exposure. However, as adults, male rats displayed symptoms 
of increased anxiety in the light-dark box, whereas other behavioral tests (social interaction, 
exploration of a novel environment) yielded no effects of adolescent stress history. Interestingly, 
these males also exhibited normal CORT responses as adults. In contrast, females with a history of 
adolescent footshock displayed very few behavioral signs of anxiety, but once again displayed a 
modestly exaggerated CORT response as adults (Lovelock & Deak, in prep). Nevertheless, the finding 
that distinct challenges imposed on females during adolescence consistently yielded exaggerated 
CORT responses in adulthood suggests that adolescence in females (but not males) may be a 
developmentally critical or sensitive period during which HPA axis reactivity is entrained. These 
findings may therefore have implications for the development of sex-biased outcomes in numerous 
disease states, as well as defining sex-specific interventions for health-related problems that emerge 
during adulthood [46]. 
The endocannabinoid system has been implicated in anti-stress mechanisms during 
adulthood [47]. Considering the influence of the endocannabinoid system in early development, it 
was demonstrated in a mouse CB1 knockout model that this receptor modulates the stress response 
during early life stages, since the lack of CB1 increased vulnerability to acute (swimming) and chronic 
(repeated bell) stress, inducing greater and prolonged freezing behaviour and decreased ultrasonic 
vocalizations [48]. In another study, early life stress resulted in diminished levels of CB1 and 
increased GR levels in the CNS of male and female rats, but these effects were prevented with late 
adolescence administration of a CB1 agonist, WIN55,212-2. Also, the CB1 agonist prevented 
impaired performance, induced by early life stress, in adult short-term memory in spatial location 
and social recognition tasks [49]. Considering that the CB1 receptor mediates CORT effects [50], it is 
possible that decreased CB1 expression during early life stress resulted in a blunted HPA axis 
response, increasing GR expression which might also impact short-term memory in adulthood. These 
results indicate that the endocannabinoid system participates in the early events of neural 
development, modelling further responses to stress, and its modulation might be a target in the 
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b. SUMO conjugation as a possible mechanism underlying stress 
related challenges 
Protein SUMOylation is a post-translational modification (PTM) regulating multiple cellular 
pathways and consists of the covalent attachment of one or many small ubiquitin-like modifiers 
(SUMO) to target proteins [51], [52]. The consequences of SUMO conjugation vary with different 
substrates and may include alterations in protein stability, protein interaction and subcellular 
localization. Importantly, in the CNS, SUMOylation is related to the modulation of many aspects of 
neuronal functions, is essential for emotionality, cognition and memory, and is also important in the 
regulation of the inflammatory response mediated by astrocytes [53], [54].  
The adrenal gland from the HPA axis is responsible for the release of glucocorticoids (GCs) in 
response to stress. Its binding to GR induces nuclear translocation and transcriptional modulation of 
different genes related to the immune system, such as the nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-κB) and the Activator protein 1, among others [55], [56]. GC binding, GR 
translocation, and transcriptional modulation [57], in turn, depends on its proper folding by a 
chaperone complex, including the Heat shock protein (Hsp) 90 and Hsp70, and immunophilins, such 
as the FK506 binding protein (FKBP) 51 and FKBP52 [58]. The fine-tuning for GR nuclear translocation 
is mediated by these immunophilins since FKBP52 promotes nucleus migration favoring GR 
transcriptional activity and FKBP51 prevents it [59], [60]. In particular, GR transcriptional activity is 
controlled by its own response, since it induces FKBP51 transcription [61], which inhibits GR action in 
the nucleus. This mechanism seems to be crucial to the correct HPA responses to stress, since 
deregulation of FKBP51/FKBP52 balance has been related to a dysfunctional activity of the HPA axis 
and stress disorders, such as depression and bipolar disorders, among others [62], [63]. These 
immunophilins could be a reasonable target for the treatment of stress-related disorders, but also 
for immune system disorders since GR also controls NF-kB transcription and the activity of other key 
inflammatory transcription factors [62]. 
It has been reported that GR activity is modulated by SUMOylation [64], [65], and is 
important for fine-tuning GR activity under cellular stress conditions [66], [67]. Also, FKBP51 is a 
target of SUMO conjugation [68] and SUMOylation of FKBP51 was suggested to be necessary for the 
inhibition of GR activity. SUMO conjugation to FKBP51 favors FKBP51 interaction with Hsp90 and its 
recruitment to the chaperone complex, thereby inhibiting GR hormone binding and migration to the 
nucleus [68]. Since over-expression of FKBP51 is associated with deregulated GR activity and 
pathological adrenal responses [63], the inhibition of FKBP51 SUMO conjugation could be an 
interesting approach to modulate deregulated inflammatory and stress-related responses [69].  
SUMO conjugation has been shown to be affected by environmental stressors such as heat-
shock and hypoxia, which are present in the development of certain inflammatory processes [67], 
but also, pro-inflammatory stimuli have been shown to activate the SUMOylation pathway and 
modulate the inflammatory response. Thus, different environmental stressors such as the early 
developmental challenges discussed in this review, might affect specific players of the HPA axis 
response and, therefore, might be a novel mechanism by which HPA axis regulation is altered. 
Furthermore, it cannot be ruled out that SUMOylation might be the common feature shared by 
these early insults, which would signify a major step forward in the study of alternative approaches 
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ii. HPG 
The HPG axis is mainly composed of 3 cell populations. A neuronal population is located in 
the preoptic area, and releases gonadotropin releasing hormone (GnRH) to the adenohypophysis, 
where another population of cells, the gonadotrophs, are located. These cells respond to GnRH by 
releasing gonadotrophins into the circulation, such as luteinizing hormone (LH) and follicle 
stimulating hormone (FSH). The last population of cells are located in the gonads, and can respond 
to gonadotrophins by releasing steroids into the circulation, which in turn can modulate the release 
of GnRH and LH differently, depending on the sex of the organism. It has been shown that neonatal 
immune challenge can interfere with reproductive physiology in adult rats by impairing sexual 
performance, diminishing testosterone in males and estradiol in females [70], [71], as well as LH 
[72], and GnRH release [73]. In particular, the effects of immune challenge on the suppression of the 
reproductive axis associate with an impaired hypothalamic function, since LPS inhibits LH release by 
decreasing GnRH pulse frequency in the hypothalamus [74], [75]. Furthermore, the hyporesponsive 
hypothalamic activity due to LPS was reported to be mediated by TNFα and IL-1β augmentation [76], 
but also by the influence of the HPA axis [77].  
Considering early life exposure to immune challenge on HPG activity, Munkhzaya et al., 
injected LPS at different PND and evaluated the reproductive axis state 3 hours later, finding 
diminished LH levels only after PND 25, suggesting that, as with the HPA axis, the HPG axis displays 
stress hyporesponsive periods (SHRP) after PND 25 [78]. Long lasting effects of LPS were shown in 
females at different PNDs, where, prior to PND 7, LPS delayed puberty onset by altering 
hypothalamic reproductive function [79]. Another study considered the consequences of early life 
immune challenge in males by injecting LPS or saline on PND 10 (during the SHRP of both HPA and 
HPG axes) and evaluating a further response to LPS on mid-late adolescence (PND 49). LPS inhibited 
LH levels in adolescence of rats treated with saline during early life, but this inhibition was prevented 
when rats were given LPS neonatally [80]. It is possible that this effect was due to endotoxin 
tolerance, since adult LPS rats also showed diminished hypothalamic immunological markers (such 
as TNFα and IL-1β) when neonatally-treated with LPS. These results also demonstrated that LPS 
challenge during SHRP somehow locks in this phenotype into future developmental stages, making 
the HPG hyporesponsive to further immunological challenge. The mechanisms underlying these 
effects seems to be mediated at least in part by a lack of LPS signaling due to diminished levels of the 
LPS receptor, TLR4 [81].  
It has been recently demonstrated in an in vivo model that the inhibitory effects of LPS were 
mediated by the endocannabinoid system [82] since hypothalamic blockade of the cannabinoid 
receptor CB1 prevented the inhibitory effects of LPS on GnRH and LH release. The endocannabinoid 
system is reported to modulate several processes, including reproduction [83] and inflammation 
[84]. Since the CB1 and CB2 receptors are expressed in microglial cells of the neonatal 
hypothalamus, endocannabinoid participation in the inflammatory effects of LPS on reproduction 
cannot be ruled out. Indeed, microglial cells exposed to LPS increased cytokine mRNA expression, 
and a specific CB2 antagonist enhanced that effect, suggesting that cannabinoids modulate cytokine 
expression in the hypothalamus through a mechanism involving the CB2 receptor [18]. Further 
studies are needed to fully characterize the participation of the endocannabinoid system in the early 
life stage-effects of an immunological challenge in adulthood. 
Cognitive function 
It is known that both peripheral and central immunological signals influence the responses 
of the CNS at behavioral and neuroendocrine levels during development [85]. Hence, early life 
insults can affect behavior of both adolescent and adult animals [24], [86] and humans [87], through 
immune and neuro-immune changes. Specifically, a pro-inflammatory phenotype has been 
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depression, but this association is most robust in patients with a history of childhood trauma 
compared to those without such history [87]. Cytokines influence cognitive processing via actions on 
vagal afferents and at the blood-brain barrier [88], which in turn regulate neural activity within 
critical regions such as the hippocampus and PFC [89]. While lifetime stress can cause atrophy in 
these regions through inflammatory and endocrine mechanisms, neonatal MS as defined in this 
article does not reportedly cause atrophy or development of a smaller hippocampus [90] or PFC [91]. 
However, MS does produce several alterations in microstructural and circuit development within 
these regions [92]. Moreover, several other models of early-life disturbances such as alcohol [93] or 
LPS exposure [11], long-term maternal deprivation, [94] or limited nesting [95], result in decreased 
neurogenesis within the hippocampus, decreased mossy-fiber density, lower dorsal hippocampal 
volume, and lower PFC volume later in life, with cognitive disturbances. These effects in animals 
have supported similar findings in humans with histories of childhood maltreatment and related 
cognitive dysfunction [96], [97]. 
Rodent models of early life stress have begun to uncover how developmental stress 
exposure may affect cognitive function via immune signaling. For example, both male and female 
adolescent rats have displayed significant deficits in the win-shift spatial working memory paradigm 
after MS, an effect that has been reproduced in several reports of early adversity induced cognitive 
dysfunction in both rodents [26], [91] and humans [96], [98]. Cognitive dysfunction as measured by 
errors in the win-shift task correlated with lower circulating levels of IL-10 in PND 35 male rats 
exposed to MS, while in females no correlation of MS-attributable win-shift errors with cytokine 
levels was found [26]. One hypothesis to explain this sex-specific correlation is that a convergent 
behavioral dysfunction may be driven by different mechanisms in males and females, with males 
more vulnerable to adolescent immune dysfunction following MS.  Further supporting a neuro-
immune mechanism underlying cognitive deficits after MS, earlier studies also showed that IL-10−/− 
male mice exhibit higher peripheral levels of the pro-inflammatory cytokines IL-1β, IL-6 and TNFα 
and more pronounced learning and memory deficits after an immune challenge with LPS, compared 
to wild type mice [99]. Moreover, direct administration of IL-10 intracerebroventricularly to male 
rats in early adolescence prevented the MS-attributable loss of PFC interneurons that are reportedly 
critical for cognitive function [24]. On the other hand, memory function has been associated with an 
adequate balance in IL-1 levels, since central alteration of physiological IL-1β levels showed impaired 
memory performance [100]. Balanced pro-inflammatory and anti-inflammatory cytokine activity 
therefore is necessary for cognitive function, and this balance can be influenced by early-life 
experiences.  
A causal relationship between adolescent pro-inflammatory activity after early-life stress 
and cognitive dysfunction may be mediated by important rate-limiting enzymes in the inflammatory 
pathway that affect neurotransmitter release. For example, the kynurenine pathway has been found 
to play important roles in several behavioral sequelae of early-life stress [89]. This pathway is 
initiated by prostaglandin-induced formation of indoleamine 2,3-dioxygenase and subsequent 
conversion of tryptophan into kynurenine, which is then converted into kynurenic acid (an NMDA 
antagonist) or quinolinic acid (an NMDA agonist). Upstream from this pathway is the prostaglandin-
synthesizing enzyme cyclooxygenase-2 (COX-2), which is also expressed at higher levels in the PFC of 
MS-exposed male adolescent rats. The role of COX-2 in cognitive dysfunction after MS was 
supported using a nonsteroidal anti-inflammatory drug that blocks COX-2; when a COX-2 inhibitor 
was administered systemically during early adolescence (PND 30-38), MS-exposed males did not 
commit more errors on the win-shift task than control-reared males.  
Converging evidence is unmasking the importance of peripheral immunological markers in 
early life stages as markers of PFC-related cognitive impairment, which may signify an interesting 
approach to deal with the effects of early stress instances on behavioral adult responses. It has been 
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about 11.5 years (usually during adolescence) [23]. This may suggest that there could be a critical 
period for intervention in order to deal with such alterations. Increasing understanding of an 
immune signaling link between developmental stress and later behavioral dysfunction may lead to 
strategies of identification and treatment of vulnerable populations. 
Concluding remarks 
Taken together, the topics of the present review highlight the repercussions of different 
kinds of threats imposed during early stages of development on further health outcomes during 
adulthood, including subsequent responses to stress at behavioral and immunological levels, and 
also the participation of the endocannabinoid system in this context. The common features of 
different early insults are summarized in Fig 1. The mechanisms underlying these effects remain 
unknown, but may include the novel influence of SUMOylation on the HPA axis, and should consider 
the influence of sex differences, since the physiological response to early stress differentially affects 
several systems such as the HPA axis and the immunological system in a sex-specific fashion. 
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Table 1:  Cytokine response during adulthood in animal models of early life stress.  
Fig 1: Common outcomes induced by early insults. Different developmental challenges such as MS, 
alcohol consumption and immune challenges can induce changes in the immune system, which in 
turn affects the adult neuroendocrine response, probably by endocannabinoid rearrangement, and 
brain development. Some of the effects inducing major neurological diseases in adulthood could be 
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Cytokine Effect Adolescent alcohol consumption Neonatal LPS Maternal separation
TNFα Pro-inflammatory Males: blunted response to further stress (7)
Females: no changes (7)
Males: enhanced response to restraint stress (13)
Females: no changes to restraint stress (13)
Males: increased baseline levels (25)
Females: no baseline changes (25)
IL-1β Pro-inflammatory Males: blunted response to further stress (7)
Females: no changes (7)
Males: enhanced response to restraint stress (13)
Females: enhanced response to restraint stress 
(13)
Males: no baseline changes (26)
Females: no baseline changes (26)
IL-6 Modulatory Males: blunted response to further stress (7)
Females: no changes (7)
Males: suppressed baseline levels (12)
Females: suppressed baseline levels (12)
Males: increased baseline levels (24)
IL-4 Modulatory Males: increased baseline levels (12)
Females: increased baseline levels (12)
Males: no baseline changes (26)
Females: no baseline changes (26)
IL-10 Modulatory Males: decreased baseline levels 
(26)
Females: no baseline changes (26)
Table 1. Cytokine responses in adulthood
 
 
 
